This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Understand the usual disbursement timing after refinance approval and actions that can speed or delay access to funds.
21,084 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Stock splits have made a comeback, and some analysts link splits to meaningful upside. This guide shows how to identi...
Two years after a spouse's death, survivors face a new tax regime. This report outlines crucial 401(k) moves to reduc...
Salesforce just announced a massive buyback, but does that mean now is the time to buy CRM stock? This guide breaks d...
Oil prices fell after Trump signaled a near term peace agreement, with front month WTI and Brent easing from earlier ...
Insider stock moves can be alarming, but they aren’t always a red flag. This guide explains how to read a fastly stoc...
When a major broker raises its bets on a fintech-insurer, investors take notice. This article breaks down the upgrade...
Investors are weighing the latest earnings from D-Wave Quantum. While losses persisted, revenue beat expectations in ...
Carlson Investments just revealed a sizable Fastly stake, sparking questions about the stock’s future. This guide bre...
Opendoor's CEO recently bought 100,000 shares, signaling confidence to shareholders. This article breaks down what t...
Insider moves can signal confidence, but they aren’t a surebet. This guide shows you how to interpret a director purc...
Investors pursue a $5,000‑a‑month after‑tax dividend target to resemble a mid‑career Indiana police officer’s take‑ho...